Challenges and standards in reporting diagnostic and prognostic biomarker studies

Clinical and Translational Science

Volumn 2, Issue 2, 2009, Pages 156-161

  Azuaje, Francisco ^a   Devaux, Yvan ^a   Wagner, Daniel ^a,b  

^a LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

^b CENTRE HOSPITALIER DE LUXEMBOURG   (Luxembourg)

Author keywords

"omic" biomarkers; Cardiovascular disease; Computers; Diagnosis; Translational research

Indexed keywords

BIOLOGICAL MARKER;

CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; COMMUNICATION PROTOCOL; DATA ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE MARKER; GENOMICS; LITERATURE; MEDICAL DOCUMENTATION; MEDICAL RESEARCH; MEDLINE; METABOLOMICS; PEER REVIEW; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PROTEOMICS; PUBLICATION; QUALITATIVE RESEARCH; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; REVIEW; STANDARDIZATION; TRANSCRIPTOMICS; VALIDATION PROCESS; CARDIOVASCULAR DISEASES; HUMAN; METABOLISM; METHODOLOGY; STANDARDS;

BIOLOGICAL MARKERS; BIOMEDICAL RESEARCH; CARDIOVASCULAR DISEASES; GUIDELINES AS TOPIC; HUMANS; PROGNOSIS; RESEARCH DESIGN;

EID: 77953364937     PISSN: 17528054     EISSN: 17528062     Source Type: Journal    
DOI: 10.1111/j.1752-8062.2008.00075.x     Document Type: Review

References (29)

1. Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001; 69: 89-95.
2. Wagner DR, Delagardelle C, Ernens I, Rouy D, Vaillant M, Beissel J. Matrix metalloproteinase-9 is a marker of heart failure after acute myocardial infarction. J Card Fail. 2006; 12: 66-72.
3. Lindholm E, Melander O, Almgren P, Berglund G, Agardh CD, Groop L, Orho-Melander M. Polymorphism in the MHC2TA gene is associated with features of the metabolic syndrome and cardiovascular mortality. PLoS ONE. 2006; 1: E64.
4. Tang T, Pankow JS, Carr JJ, Tracy RP, Bielinski SJ, North KE, Hopkins PN, Kraja AT, Arnett DK. Association of sICAM-1 and MCP-1 with coronary artery calcification in families enriched for coronary heart disease or hypertension: The NHLBI Family Heart Study. BMC Cardiovasc Disord. 2007; 7: 30
5. Timofeeva AV, Goryunova LE, Khaspekov GL, Kovalevskii DA, Scamrov AV, Bulkina OS, Karpov YA, Talitskii KA, Buza VV, Britareva VV, Beabealashvilli RSh. Altered gene expression pattern in peripheral blood leukocytes from patients with arterial hypertension. Ann N Y Acad Sci. 2006; 1091: 319-335.
6. Xie Q, Ratnasinghe LD, Hong H, Perkins R, Tang ZZ, Hu N, Taylor PR, Tong W. Decision forest analysis of 61 single nucleotide polymorphisms in a case-control study of esophageal cancer. BMC Bioinformatics. 2005; 6 (Suppl 2): S4.
7. Chittenden TW, Sherman JA, Xiong F, Hall AE, Lanahan AA, Taylor JM, Duan H, Pearlman JD, Moore JH, Schwartz SM, Simons M. Transcriptional profiling in coronary artery disease: Indications for novel markers of coronary collateralization. Circulation. 2006; 114: 1811-1820.
8. Chen DP, Weber SC, Constantinou PS, Ferris TA, Lowe HJ, Butte AJ. Novel integration of hospital electronic medical records and gene expression measurements to identify genetic markers of maturation. Pac Symp Biocomput. 2008; 243-254.
9. Camargo A, Azuaje F. Identification of dilated cardiomyopathy signature genes through gene expression and network data integration. Genomics. 2008; 92: 404-413.
10. Wang Y, Barbacioru CC, Shiffman D, Balasubramanian S, Iakoubova O, Tranquilli M, Albornoz G, Blake J, Mehmet NN, Ngadimo D, Poulter K, Chan F, Samaha RR, Elefteriades JA. Gene expression signature in peripheral blood detects thoracic aortic aneurysm. PLoS ONE. 2007; 2: E1050.
11. Arab S, Gramolini AO, Ping P, Kislinger T, Stanley B, van Eyk J, Ouzounian M, MacLennan DH, Emili A, Liu PP. Cardiovascular proteomics: tools to develop novel biomarkers and potential applications. J Am Coll Cardiol. 2006; 48: 1733-1734.
12. Sabatine MS, Liu E, Morrow DA, Heller E, McCarroll R, Wiegand R, Berriz GF, Roth FP, Gerszten RE. Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation. 2005; 112: 3868-3875.
13. Sawyers CL. The cancer biomarker problem. Nature. 2008; 452: 548-552.
14. Gerszten RE, Wang TJ. The search for new cardiovascular biomarkers. Nature. 2008; 451: 949-952.
15. Sterne JA, Davey-Smith G. Sifting the evidence - what's wrong with significance tests? BMJ. 2001; 322: 226-231.
16. Jafari P, Azuaje F. An assessment of recently published gene expression data analyses: Reporting experimental design and statistical factors. BMC Med Inform Decis Mak. 2006; 6: 27.
17. Ioannidis JP. Limitations are not properly acknowledged in the scientific literature. J Clin Epidemiol. 2007; 60: 324-329.
18. Kostka D, Spang R. Microarray based diagnosis profits from better documentation of gene expression signatures. PLoS Comput Biol. 2008; 4 (2): E22.
19. Smidt N, Rutjes AW, Van Der Windt DA, Ostelo RW, Bossuyt PM, Reitsma JB, Bouter LM, de Vet HC. The quality of diagnostic accuracy studies since the STARD statement: Has it improved? Neurology. 2006; 67(5): 792-797.
20. Wood IA, Visscher PM, Mengersen KL. Classification based upon gene expression data: Bias and precision of error rates. Bioinformatics. 2007; 23: 1363-1370.
21. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Lijmer JG, Moher D, Rennie D, de Vet HC. Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative. BMJ. 2003; 326: 41-44.
22. The CONSORT statement. Available at: http://www.consort-statement.org. Accessed on 8 December 2008.
23. The Equator Network. Available at: http://www.equator-network.org. Accessed on 8 December 2008.
24. STARD statement. Available at: http://www.stard-statement.org. Accessed on 8 December 2008.
25. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: A tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003; 3: 25.
26. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet. 1999; 354: 1896-1900.
27. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000; 283: 2008-2012.
28. Smidt N, Rutjes AW, Van Der Windt DA, Ostelo RW, Bossuyt PM, Reitsma JB, Bouter LM, de Vet HC. Reproducibility of the STARD checklist: An instrument to assess the quality of reporting of diagnostic accuracy studies. BMC Med Res Methodol. 2006; 6: 12.
29. Cobo E, Selva-O'Callagham A, Ribera JM, Cardellach F, Dominguez R, Vilardell M. Statistical reviewers improve reporting in biomedical articles: A randomized trial. PLoS OEE. 2007; 2(3): e332.